Sumanbutler - Latest News 2026-07-21T13:18:15+00:00 urn:uuid:29f3045a-8f9c-38b8-643d-e199490c34ca The “Cell Therapy Manufacturing Market (3rd Edition), 2019-2030 urn:uuid:618126a4-c745-b3a8-8294-1424b9bef528 2021-09-21T10:56:59+00:00 With over 280 therapies under evaluation, the stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030, claims Roots Analysis urn:uuid:e7bf6d8e-a357-7531-d59c-af1d825e54ec 2021-09-21T10:46:10+00:00 The ophthalmic drugs contract manufacturing market is estimated to be worth USD 1.7 billion in 2030, predicts Roots Analysis urn:uuid:2013de3a-94b1-2d9f-fd7f-484a640d3b24 2021-09-15T08:38:14+00:00 Retention services to the pharmaceutical and medical devices industries, employing a variety of outreach methods and solutions, claims Roots Analysis urn:uuid:c6e16fcd-6c14-c829-5a32-5593d86878ad 2021-09-15T08:36:26+00:00 The medical device label contract manufacturing market is projected to reach USD 509 million in 2030, predicts Roots Analysis urn:uuid:b235e403-b187-8423-3fa9-7539ef943007 2021-09-01T07:07:35+00:00 The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030, predicts Roots Analysis urn:uuid:85cdba98-ee0e-cfc8-85ac-5b0971c62d68 2021-09-01T05:24:10+00:00 Growing at an annualized rate of over 16.5%, the cell therapy manufacturing market is estimated to reach close to USD 11 Billion by 2030 urn:uuid:3f7fe845-2d9a-deac-d163-15e1800bae17 2021-08-27T08:11:08+00:00 Global Psychedelic Therapeutics Market by Roots Analysis urn:uuid:f5514c41-a02d-eb92-d039-5109cd5fa22e 2021-08-20T09:53:48+00:00 More than 200 preventive vaccines, developed by both industry and non-industry players, are being evaluated in clinical stages of development urn:uuid:9731b201-19c4-3a1b-3d75-0d6e90be98db 2021-08-16T04:22:05+00:00 The non-invasive cancer diagnostics market is estimated to be worth around USD 20.1 billion by 2030, predicts Roots Analysis urn:uuid:8991fd33-67b8-a1af-a299-5a62b1373f5d 2021-08-12T09:56:08+00:00 More than 85 small molecule protein degraders are currently being evaluated for the treatment of various disease indications urn:uuid:e6100d8f-d5af-1f09-0936-82a45d978b8f 2021-08-12T07:23:39+00:00 The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030, predicts Roots Analysis urn:uuid:cca3fa79-ffc8-a869-84d6-e639ce5af77f 2021-08-05T05:54:58+00:00 The targeted protein degradation enabling technologies market, featuring a healthy pipeline of novel therapeutics urn:uuid:402fd8a4-b348-bd73-363f-7250040c5fe8 2021-08-05T05:52:35+00:00 The contract manufacturing market for live biotherapeutics and microbiome products urn:uuid:277bdab5-e3fc-45f3-ce64-ccc0fb38f09e 2021-07-30T07:45:47+00:00 The medical device CRO market is estimated to be worth USD 15.7 billion in 2030, predicts Roots Analysis urn:uuid:6e95ce8d-a407-99db-9d1c-758986425a66 2021-07-30T07:35:52+00:00